<p>Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy

Published:2019-12 Issue: Volume:Volume 12 Page:10989-10995
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Zhou Lu^ORCID,Shi Huiping,Shi Wenyu,Yang Li,Zhang Yaping,Xu Mengqi,Chen Xiufang,Zhu Yanv,Mu Hui,Wan Xiaochun,Yang Zhonghua,Zeng Ying,Liu Hong

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy;Blood Cancer Journal;2024-03-06

2. Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations;Leukemia;2023-01-27

3. Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies;Current Hematologic Malignancy Reports;2022-10-19

4. B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics;International Journal of Molecular Sciences;2022-10-05

5. Understanding and Monitoring Chronic Myeloid Leukemia Blast Crisis: How to Better Manage Patients;Cancer Management and Research;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP